Fig. 9.

Effects of long-term treatments with spadin. Spadin–MedinGel formulation and placebo–MedinGel were subcutaneously injected in the neck of mice. Immobility times were measured in FST at 1, 2, or 4 weeks (W1, W2, W4) after injection. For each week, values obtained with formulations were compared with their corresponding placebo values by using the Mann-Whitney test. PLB, placebo, *p < 0.05